Study of Elobixibat (A3309) in Patients With Chronic Idiopathic Constipation

Completed · Phase 2 · Has a placebo group

Conditions studied: Constipation, Chronic Constipation

In brief

The purpose of this trial is to determine the efficacy and safety of A3309 administered to patients with chronic idiopathic constipation.

Key facts

Study ID

NCT01007123

Run by

Albireo

People needed

190

Starts

2009-11-01

Expected to finish

2010-10-01

Last updated by the study team

2017-03-22

Who can join

Age: 20 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient meets protocol specified criteria for constipation
• Patient has successfully completed study requirements with no clinically relevant findings for physical exam, ECG, laboratory tests and colonoscopy as applicable

You may not qualify if…

• Medical history or medical condition that would not make the patient a good candidate for the study or limit the patient´s ability to complete the study
• Patient reports loose stools
• Patient has IBS with pain/discomfort as predominant symptom
• Patient needs medications prohibited as specified in the protocol

Where it is running

• Albireo Investigative Site — Huntsville, Alabama, United States
• Albireo Investigative Site — Chandler, Arizona, United States
• Albireo Investigative Site — Phoenix, Arizona, United States
• Albireo Investigative Site — Anaheim, California, United States
• Albireo Investigative Site — Encinitas, California, United States
• Albireo Investigative Site — San Diego, California, United States
• Albireo Investigative Site — Colorado Springs, Colorado, United States
• Albireo Investigative Site — Boynton Beach, Florida, United States
• Albireo Investigative Site — Inverness, Florida, United States
• Albireo Investigative Site — Peoria, Illinois, United States
• Albireo Investigative Site — Clive, Iowa, United States
• Albireo Investigative Site — Davenport, Iowa, United States
• Albireo Investigative Site — Mission, Kansas, United States
• Albireo Investigative Site — Overland Park, Kansas, United States
• Albireo Investigative Site — Monroe, Louisiana, United States
• Albireo Investigative Site — Shreveport, Louisiana, United States
• Albireo Investigative Site — Annapolis, Maryland, United States
• Albireo Investigative Site — Baltimore, Maryland, United States
• Albireo Investigative Site — Hollywood, Maryland, United States
• Albireo Investigative Site — Chesterfield, Michigan, United States
• Albireo Investigative Site — Henderson, Nevada, United States
• Albireo Investigative Site — Marlton, New Jersey, United States
• Albireo Investigative Site — Albuquerque, New Mexico, United States
• Albireo Investigative Site — Great Neck, New York, United States
• Albireo Investigative Site — Charlotte, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.